Take Solutions Ltd Share Price Today - Take Solutions Ltd Stock Price Live NSE/BSE

Take Solutions Ltd

NSE: TAKE BSE: 532890

₹42.69

(-2.00%)

Fri, 08 May 2026, 03:33 pm

MTF 5xInvest in Take Solutions Ltd with 5x Leverage Buy with MTF

Market Cap6.41B

PE Ratio388.09

Dividend0

Technology Services

Information Technology Services

24.5K

Take Solutions Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
512.15
Net Profit
37.47
P/B
4.82
Sector P/E
60.07
P/E
2.64
EV/EBITDA
2.41
Debt/Equity (Industry)
0.58
Interest Cover (Industry)
3.72
ROCE (Industry)
6.51
RONW (Industry)
5.73
ROE
11.05
ROCE
0.77
Debt/Equity
3.18
EPS (TTM)
0.01
Dividend Yield
0
Book Value
1.74
Interest Cover
1.41

Analysis

all

Pros

Dividends after 3 years are expected to be thoroughly covered by earnings (8.4x coverage).
Cash flow for TAKE Solutions is expected to increase by more than 50% in 2 years time.
TAKE Solutions's earnings are expected to grow significantly at over 20% yearly.
TAKE Solutions's earnings growth is expected to exceed the India market average.
TAKE Solutions's earnings growth is expected to exceed the low risk savings rate of 7.2%.

Cons

Unable to calculate sustainability of dividends as TAKE Solutions has not reported any payouts.
Unable to evaluate TAKE Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate TAKE Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.
TAKE Solutions is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
TAKE Solutions is making a loss, therefore interest payments are not well covered by earnings.

Financials

No Result Found

Ratios

No Result Found

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	0	0	5.19	53.34	53.41
FII	0.29	0.56	0	0	0
DII	0	0.00	0	0	0.01
Public	99.71	99.44	94.81	46.66	46.58
Government	0	0	0	0	0

Technical Analysis

RSI

MACD

50 DMA

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	-	-	-	-	-	-	-
Fibonacci	-	-	-	-	-	-	-
Camarilla	-	-	-	-	-	-	-

Pivots Level: Classic

Pivot Point

LTP: -

Moving Average

SMAEMA

Period

Value

10-EMA
-
20-EMA
-
30-EMA
-
50-EMA
-
100-EMA
-
200-EMA
-

Announcement Date	Purpose	Action	Ex Date
14 Feb 2026	board-meetings	Quarterly Results
11 Feb 2026	egm
16 Sept 2025	agm
08 Jul 2025	egm
17 Sept 2024	egm
07 Jul 2024	agm	Annual General Meeting	08 Aug 2024
30 May 2024	agm
17 Jul 2023	agm
07 Jul 2023	agm	Annual General Meeting	08 Aug 2023
28 Nov 2022	agm

Peer Comparison

No Result Found

Take Solutions Ltd

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Take Solutions Ltd About

Take Solutions In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Our global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.

Industry

Miscellaneous

Founded

2000

Headquarters

CEO

Employees

Contact

Website

http://www.takesolutions.com

investorrelations@takesolutions.com

Phone

91-044-24617358/24617359

Location

No 27 Tank Bund Road, Nungambakkam, Chennai, Tamil Nadu, 600034

Year	History
2017	Take Solutions receives Golden Peacock Award for Excellence in Corporate Governance. Launched the Gemini Series Android App for Smartphones. Launched Labeling Assessment Express to improve End-to-End labeling for Life Sciences
2018	TAKE Solutions to receive coveted Golden Peacock Award for Excellence in Corporate Governance for 2 years in succession. TAKE recognised in CIO Review's 20 Most Promising Pharma and Life Sciences Tech Companies. Inaugurated satellite hub in Chennai to deliver end-to-end dossier submission for APAC region for one of the largest global pharma companies.
2019	Acquired DataCeutics, an American Clinical Data Sciences services company. Acquired US-based, full-service contract research organization (CRO) and health-research company KAI Research. Everest Group's Life Sciences Clinical Trials Products PEAK Matrix Assessment 2019 recognized Navitas Life Sciences as a Major Contender.
2020	Navitas Life Sciences is Major Contender in Everest Group's Clinical Development Platforms Vendor Landscape with Products PEAK Matrix Assessment 2020.
2021	Navitas Life Sciences has been named as a Top 10 Pharma and Life Sciences Tech Solution Provider 2021 by Industry Tech Outlook. Everest Group assesses Navitas Life Sciences as a Major Contender in their Pharmacovigilance and Complaint Management Operations Services PEAK Matrix Assessment 2021. TAKE Solutions forms strategic partnership with H.I.G. Capital to accelerate growth of Navitas Life Sciences.

Client Name	Order Side	QTY	Avg Price	Date
ZUBER TRADING LLP	Buy	1019462	49.16	17 Apr 2026
AKARSHIKA TRADERS LLP	Buy	1225469	40.52	05 Jan 2026
AKARSHIKA TRADERS LLP	Sell	600000	40.6	05 Jan 2026
ALIA COMMOSALES LLP	Buy	1210000	38.83	23 Dec 2025
ALIA COMMOSALES LLP	Sell	85428	37.1	23 Dec 2025
ALIA COMMOSALES LLP	Sell	822987	36.51	22 Dec 2025
ALIA COMMOSALES LLP	Buy	68584	36.3	22 Dec 2025
AKARSHIKA TRADERS LLP	Buy	353665	31.99	26 Nov 2025
AKARSHIKA TRADERS LLP	Sell	766747	30.82	26 Nov 2025
AKARSHIKA TRADERS LLP	Buy	831343	30.25	18 Nov 2025

Take Solutions Ltd News

Take Solutions enters longevity market under Reg 30

Take Solutions Limited announces strategic entry into India's longevity and anti-aging market through Regulation 30 filing, targeting science-backed nutraceuticals and biohacking solutions.

23 Apr 2026

companies

Take Solutions enters longevity market under Reg 30

Take Solutions Limited announces strategic entry into India's longevity and anti-aging market through Regulation 30 filing, targeting science-backed nutraceuticals and biohacking solutions.

17 Apr 2026

companies

Take Solutions Files Q4FY26 Compliance Certificate

Take Solutions Limited submitted its quarterly compliance certificate under SEBI regulations for Q4FY26, confirming adherence to dematerialisation requirements through its registrar MUFG Intime India.

13 Apr 2026

companies

Take Solutions Launches ₹50M Innovation Fund

Take Solutions announces Rs. 50 million innovation fund targeting AI, deep-tech, and digital health startups to capitalize on India's $400-500 billion health market opportunity.

06 Apr 2026

companies

TAKE Solutions Appoints New Statutory Auditors

TAKE Solutions Limited's board approved appointment of M/s. A. Raghavendra Rao & Associates as statutory auditors to fill casual vacancy, effective March 26, 2026, subject to shareholder approval.

27 Mar 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800